Please login to the form below

Not currently logged in
Email:
Password:

government strategy

This page shows the latest government strategy news and features for those working in and with pharma, biotech and healthcare.

NHS test and trace system ‘still not good enough’ says health leader

NHS test and trace system ‘still not good enough’ says health leader

According to the government’s Scientific Advisory Group (SAGE), 80% of the contacts of people with the virus need to self-isolate to prevent the infection rate rising. ... the NHS COVID-19 App and NHS Test and Trace, on the government’s recent change

Latest news

More from news
Approximately 5 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Nevertheless, Osbourn said it is encouraged by the government’s commitment to an industrial strategy that safeguards life sciences.

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    ecosystem. MSD’s expansion over the coming years will help the company hold the government to its promises included in the Life Sciences Sector Deal. ... Louise was also involved in the launch of the government’s Industrial Strategy last year, which

  • Lighting the way Lighting the way

    That new industrial strategy (see p7) hands a prominent role to life sciences, naming it as the first of 10 strategic pillars that will be leant upon to support the ... She noted that engaging with the government on the new Life Sciences Strategy (see p7)

  • Bringing about digital health change Bringing about digital health change

    Regulators are not a problem, Valencia states, and providers - such as the NHS - have shown openness to change, which is enshrined in the UK government's Five Year Forward strategy. ... Digital inspiration for pharma on mobile, social media, strategy,

  • Russian innovation at the crossroads Russian innovation at the crossroads

    The government came up with a strategy to develop high technology sectors such as pharmaceuticals, electronics, nanotechnology and others. ... During the first three years of Strategy's implementation (2011-2013), the key objective for the government was

More from intelligence
Approximately 3 fully matching, plus 7 partially matching documents found.

Latest appointments

  • IFPMA appoints Fumie Griego as assistant director general IFPMA appoints Fumie Griego as assistant director general

    She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals ... His role in

  • New health ministers and re-appointments after reshuffle New health ministers and re-appointments after reshuffle

    Jeremy Hunt and George Freeman have kept their health and life science roles but there are new faces for pharma after the UK government reshuffles the Department of Health after ... the uptake of new drugs and med tech, and the government's life sciences

  • Astellas adds to US comms team Astellas adds to US comms team

    Marty Golden appointed VP, government affairs. Astellas continued to strengthen its communication and public affairs efforts in the US with the appointment of Marty Golden as VP, government affairs. ... In this role, Golden will lead federal government

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Covid-19: what could it mean for the diabetic population?

    UK covid-19 strategy. A key element of the Government’s strategy to tackle covid-19 has involved social distancing to avoid contracting the virus, with shielding in place for certain ... NHS strategy and diabetes. The covid-19 pandemic has been forcing

  • Artificial Intelligence in healthcare

    In a recent government publication covering industrial strategy, the task of becoming a world leader in employing artificial intelligence (AI) as part of a data driven economy was recognised as one ... HM Government; 27 November 2017. 2. Schwab K. The

  • What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government

    GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? ... Either way, a Corbyn-led government would be far from business as usual for leaders and investors in the UK.

  • Shining a light on the true cost of patient care

    When Sir John Bell recently published his recommendations for the Life Sciences strand of the Government’s Industrial Strategy, he said that the NHS’s structure gives it data sharing opportunities ... However, before this can happen, the Government

  • Getting to grips with Russia’s healthcare market

    the health care industry, in particular”. Increasing GDP, rising consumer incomes and government strategy to transform the nation’s healthcare are the key growth drivers. With the total value of the ... pharmaceutical market projected to reach 37

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics